Table 2.

Relationship between GS28 expression and clinicopathological parameters in CRC patients

Parameter	GS28 expression (n = 214a)		P value
	nuclear predominant	non-nuclear predominant
Sex			0.987
Male	16	116
Female	10	72
Age			0.452
≤ 55 years	5	49
> 55 years	21	139
Tumour stage			0.045*
T1, T2 or T3	16	148
T4	10	40
Nodal stage			0.654
N0 or N1	18	138
N2	8	50
Metastasis			0.102
M0	22	176
M1	4	12
Lymphatic invasion			0.738
Absent	10	66
Present	16	122
Vascular invasion			0.822
Absent	23	169
Present	3	19
Perineural invasion			0.064
Absent	14	136
Present	12	52
Differentiation			0.644
Well-to-moderate	24	178
Poor	2	10
Site			0.764
Right colon	7	56
Left colon or rectum	19	132

^aOne case with GS28 non-immunoreactivity is included in the non-nuclear predominant subgroup.

* Statistically significant

CRC: colorectal cancer